HAXBY GROUP SCARBOROUGH
LAWRENCE HOUSE MED CTR, 1A BELGRAVE CRESCENT, SCARBOROUGH
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 121 | 135 | 89.6% | |
| CKD 4 | 2008 | 97 | 117 | 82.9% | |
| CKD 5 | 2009 | 32 | 35 | 91.4% | |
| CKD 5 | 2010 | 10 | 11 | 90.9% | |
| CKD 5 | 2011 | 8 | 9 | 88.9% | |
| CKD 5 | 2012 | 5 | 5 | 100.0% | |
| CKD 5 | 2013 | 6 | 7 | 85.7% | |
| CKD003 | 2014 | 9 | 10 | 90.0% | |
| CKD003 | 2015 | 6 | 6 | 100.0% | |
| NM84 | 2016 | 9 | 10 | 90.0% | |
| NM84 | 2017 | 8 | 9 | 88.9% | |
| NM84 | 2019 | 87 | 121 | 71.9% | |
| NM84 | 2020 | 81 | 115 | 70.4% | |
| NM84 | 2022 | 64 | 93 | 68.8% | |
| NM84 | 2023 | 57 | 80 | 71.2% |
